Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failure.
Lytvyn Y, Scholtes RA, Boorsma EM, Sridhar VS, Kugathasan L, Liu H, Lovblom LE, Handoko L, Mosterd CM, Floras JS, Burns K, Osuntokun T, Voors A, van Raalte DH, Heerspink HJL, Cherney DZI.
Lytvyn Y, et al. Among authors: floras js.
Physiol Rep. 2025 Apr;13(7):e70275. doi: 10.14814/phy2.70275.
Physiol Rep. 2025.
PMID: 40207988
Free PMC article.
Clinical Trial.